As of 2025-07-09, the Relative Valuation of BridgeBio Pharma Inc (BBIO) is (64.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.19 USD, the upside of BridgeBio Pharma Inc based on Relative Valuation is -249.7%.
The range of the Relative Valuation is (41.37) - (84.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 24.1x | 18.8x |
| Forward P/E multiples | 9.5x - 24.5x | 18.0x |
| Fair Price | (41.37) - (84.71) | (64.64) |
| Upside | -195.8% - -296.1% | -249.7% |
| Date | P/E |
| 2025-07-08 | -12.28 |
| 2025-07-07 | -12.37 |
| 2025-07-03 | -12.50 |
| 2025-07-02 | -12.18 |
| 2025-07-01 | -12.16 |
| 2025-06-30 | -12.27 |
| 2025-06-27 | -12.75 |
| 2025-06-26 | -12.83 |
| 2025-06-25 | -12.62 |
| 2025-06-24 | -12.64 |
| 2025-06-23 | -11.99 |
| 2025-06-20 | -11.86 |
| 2025-06-18 | -11.37 |
| 2025-06-17 | -11.39 |
| 2025-06-16 | -11.69 |
| 2025-06-13 | -11.31 |
| 2025-06-12 | -11.27 |
| 2025-06-11 | -11.10 |
| 2025-06-10 | -11.40 |
| 2025-06-09 | -11.09 |
| 2025-06-06 | -10.98 |
| 2025-06-05 | -10.90 |
| 2025-06-04 | -10.81 |
| 2025-06-03 | -10.67 |
| 2025-06-02 | -10.08 |
| 2025-05-30 | -9.74 |
| 2025-05-29 | -9.49 |
| 2025-05-28 | -9.17 |
| 2025-05-27 | -9.41 |
| 2025-05-23 | -9.48 |
| 2025-05-22 | -9.37 |
| 2025-05-21 | -9.34 |
| 2025-05-20 | -9.58 |
| 2025-05-19 | -9.58 |
| 2025-05-16 | -9.62 |
| 2025-05-15 | -9.59 |
| 2025-05-14 | -9.57 |
| 2025-05-13 | -9.45 |
| 2025-05-12 | -10.14 |
| 2025-05-09 | -9.71 |
| 2025-05-08 | -9.91 |
| 2025-05-07 | -10.18 |
| 2025-05-06 | -10.50 |
| 2025-05-05 | -10.86 |
| 2025-05-02 | -10.96 |
| 2025-05-01 | -10.92 |
| 2025-04-30 | -10.90 |
| 2025-04-29 | -10.35 |
| 2025-04-28 | -10.20 |
| 2025-04-25 | -10.32 |